MedTrace Logo

Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing Vascular Reconstruction With Polytetrafluoroethylene (PTFE) Prosthesis

NCT00163592 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2006-10-23

No results posted yet for this study

Summary

This study investigates if the time to hemostasis can be reduced by application of Tissucol® onto femoral vascular anastomoses with PTFE prostheses compared to standard methods, such as compression with swabs.

Conditions

  • Femoral Vascular Anastomosis

Interventions

DRUG

Tissucol®

PROCEDURE

Control: Conventional treatment, i.e. compression with swabs

Sponsors & Collaborators

  • Baxter Healthcare Corporation

    lead INDUSTRY

Principal Investigators

  • Thomas Bürger, MD · University Clinics of Magdeburg, Germany

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30
Completion
2004-02-29

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00163592 on ClinicalTrials.gov